LRFN3 activators refer to a collection of chemical compounds that, while not having a direct interaction with LRFN3, can influence its function by modulating the synaptic pathways in which LRFN3 is involved. LRFN3, or SALM3, is primarily recognized for its role as a synaptic adhesion molecule, essential for synapse organization and synaptic function. Due to this key role, any chemical that modulates synaptic activity or synaptic plasticity can have downstream implications for LRFN3. Compounds like Aniracetam, which enhance AMPA receptor responses, and D-Cycloserine, a partial NMDA receptor agonist, are significant as they modulate synaptic plasticity. As synaptic plasticity is pivotal for the strength and formation of synapses, it's plausible that these compounds indirectly affect the activity of synaptic adhesion molecules like LRFN3. Phorbol 12-myristate 13-acetate (PMA) is another compound that activates protein kinase C (PKC). Given that PKC plays a notable role in synaptic modulation, the activation or inhibition of this kinase can impact the interactions of LRFN3 at the synapse.
Additionally, neurotransmission is a fundamental aspect of synaptic activity. Compounds such as Picrotoxin and Bicuculline, which are GABA_A receptor antagonists, modulate neurotransmission. Alterations in synaptic activity can have implications for synaptic organization and the interactions of adhesion molecules such as LRFN3. Similarly, excitatory neurotransmission, influenced by compounds like CNQX (an AMPA receptor antagonist) or Kainic acid (a kainate receptor activator), can also affect the role of LRFN3 in synapse organization.Furthermore, ionic channels play a paramount role in synaptic function. Nimodipine, an L-type calcium channel blocker, and Tetrodotoxin, a sodium channel blocker, are examples of compounds that can affect ionic flow within neurons. By altering neuronal excitability, these compounds can have downstream effects on synaptic organization and the function of adhesion molecules, including LRFN3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aniracetam | 72432-10-1 | sc-203514 sc-203514A | 50 mg 250 mg | $113.00 $447.00 | ||
Enhances AMPA receptor responses, which can indirectly stimulate synapse formation and potential modulation of LRFN3's adhesion activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC). Given the importance of PKC in synaptic modulation, PMA can influence LRFN3's synaptic interactions. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $107.00 $362.00 | 2 | |
As an agonist of NMDA receptors, it can modulate synaptic plasticity which can indirectly involve LRFN3's adhesion function in synapse organization. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $27.00 $75.00 $139.00 $520.00 | 4 | |
Partial NMDA receptor agonist. By modulating NMDA receptor activity, it can influence synapse formation and potentially LRFN3's role in it. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
PDE4 inhibitor enhancing cAMP levels. cAMP affects synaptic function, possibly influencing LRFN3-mediated synaptic adhesion. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $66.00 $280.00 $1300.00 | 11 | |
GABA_A receptor antagonist. Modulates neurotransmission, which might indirectly influence LRFN3's synaptic adhesion activity. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $80.00 $275.00 | ||
GABA_A receptor antagonist, influencing inhibitory synaptic transmission which might impact LRFN3's synaptic role. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
L-type calcium channel blocker affecting calcium influx in neurons. Could influence LRFN3's role in synapse organization. | ||||||
Kainic acid monohydrate | 58002-62-3 | sc-269283 | 10 mg | $270.00 | ||
Activates kainate receptors, affecting excitatory neurotransmission. This may influence LRFN3's function in synapse organization. | ||||||
6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-Dione | 118876-58-7 | sc-478080 | 5 mg | $70.00 | 1 | |
AMPA receptor antagonist that modulates excitatory synaptic activity, potentially influencing LRFN3's synaptic adhesion function. | ||||||